The incidence and significance of anti-natalizumab antibodies - Results from AFFIRM and SENTINEL

Calabresi P. A., Giovannoni G., Confavreux C., Galetta S. L., Havrdova E., Hutchinson M., ...More

NEUROLOGY, vol.69, no.14, pp.1391-1403, 2007 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 69 Issue: 14
  • Publication Date: 2007
  • Doi Number: 10.1212/01.wnl.0000277457.17420.b5
  • Journal Name: NEUROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1391-1403
  • Istanbul University Affiliated: Yes


Objective: To determine the incidence and clinical effects of antibodies that develop during treatment with natalizumab.